Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9087400 | Journal of Pain and Symptom Management | 2005 | 14 Pages |
Abstract
The origins of the WHO Cancer Pain Relief Program (the Analgesic Ladder) and its research basis in two very different research traditions, one at Memorial Sloan-Kettering Cancer Center in New York, the other at St. Christopher's Hospice in London, are discussed. The Sloan-Kettering group emphasized precise relative differences in analgesic effects of various drugs, whereas Twycross at St. Christopher's used patient well-being as the crucial benchmark. Despite these differences, both traditions presented evidence of the safe and effective use of strong opioids for cancer pain relief, in a setting of individualized attention and close physician monitoring. The success and limitations of the Ladder as a global health policy are briefly addressed.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Marcia PhD,